- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
Warsaw Today
By the People, for the People
B. Metzler seel. Sohn & Co. AG Increases Stake in Zimmer Biomet
The German investment firm boosts its position in the medical equipment provider by over 250%.
Mar. 11, 2026 at 7:19am
Got story updates? Submit your updates here. ›
B. Metzler seel. Sohn & Co. AG, a German investment firm, has increased its stake in Zimmer Biomet Holdings, Inc. (NYSE: ZBH) by 255.1% in the third quarter, according to a recent SEC filing. The firm now owns 19,618 shares of the medical equipment provider's stock, valued at $1.93 million as of its latest disclosure.
Why it matters
Zimmer Biomet is a major player in the orthopedic and musculoskeletal healthcare industry, producing a wide range of joint replacement systems, trauma and extremities implants, and other medical devices. The increase in B. Metzler's stake suggests the firm sees long-term growth potential in Zimmer Biomet's business.
The details
According to the SEC filing, B. Metzler seel. Sohn & Co. AG purchased an additional 14,093 shares of Zimmer Biomet in the third quarter, bringing its total position to 19,618 shares. This represents a 255.1% increase in the firm's stake in the medical equipment provider.
- B. Metzler seel. Sohn & Co. AG increased its stake in Zimmer Biomet during the third quarter of 2026.
The players
B. Metzler seel. Sohn & Co. AG
A German investment firm that has increased its stake in Zimmer Biomet by over 250% in the third quarter of 2026.
Zimmer Biomet Holdings, Inc.
A global medical device company focused on musculoskeletal healthcare, headquartered in Warsaw, Indiana.
The takeaway
The significant increase in B. Metzler's stake in Zimmer Biomet suggests the German investment firm sees strong growth potential in the medical equipment provider's business, which could signal positive news for the company's future performance.
